RxDoctor Payments Data

Victoria Randall, NP

Gerontology · Monroe, LANPI 1396478830

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 31.5% of the total. That places this record below the midpoint for gerontology clinicians in LA, where the typical reported total is $485.

$496in general payments, 2019–2025

Across 23 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$156
  • Lundbeck LLC$80
  • Bayer$67
  • Corcept Therapeutics$51
  • Lilly USA, LLC$36
  • AstraZeneca$20
  • plus $85 from 5 others

What the payments were for

  • Food & beverage$496100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$496 in reported general payments places this provider in the 50th percentile of 64 gerontology providers in Louisiana.

See all gerontology providers in Louisiana

Medicare billing

Part B allowed, 2024
$225,630
Medicare patients
264
Services billed
3,827

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole24$17,596
EliquisApixaban41$12,697
TradjentaLinagliptin29$7,522
Megestrol Acetate25$3,957
Metolazone30$2,806
Potassium Chloride72$2,082
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav43$1,729
CefuroximeCefuroxime Axetil28$1,296
Amlodipine Besylate97$1,115
Divalproex Sodium31$1,105
Levothyroxine Sodium63$1,043
Sucralfate13$999
Midodrine Hcl27$972
Hydralazine Hcl28$939
Doxycycline Hyclate26$893

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCOlanzapine$36$38914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 64 gerontology providers in Louisiana.

Other gerontology in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →